Cardiac Arrhythmias, Cardiac Disease, Cardiology, Genetic Disease, Genetic Disorder
Conditions
Keywords
Cardiogenetic
Brief summary
The goal of this observational study is to enroll all patients evaluated at the specialized Cardiogenetic Center within the Cardiology Department of the University of Ferrara, Italy. The primary aim of the registry is to collect comprehensive clinical, genetic, and electrophysiological data from individuals with suspected or confirmed arrhythmogenic conditions. By systematically documenting patient demographics, family history, clinical presentations, diagnostic findings, and treatment outcomes, the registry seeks to enhance our understanding of the genetic basis and clinical implications of genetically driven arrhythmias and systemic syndromes. This registry will facilitate long-term follow-up of enrolled patients to assess the natural history of arrhythmogenic disorders and the effectiveness of various therapeutic interventions. Additionally, it aims to identify potential risk factors associated with adverse outcomes, such as sudden cardiac death or major arrhythmic events.
Detailed description
Cardiogenetics is essential in daily clinical practice, providing critical insights into the genetic basis of inherited cardiovascular conditions. This knowledge enables more accurate diagnoses, risk assessments, and personalized management strategies for patients. By understanding the genetic underpinnings of arrhythmias and other heart diseases, healthcare providers can identify at-risk individuals and their family members, facilitating early intervention and preventive measures. Establishing an observational registry for these conditions is vital, as it systematically collects data on patient demographics, clinical presentations, genetic findings, and treatment outcomes. This comprehensive database enhances our understanding of the natural history and variability of genetic cardiovascular disorders while supporting research efforts aimed at developing improved diagnostic tools and therapeutic approaches. Ultimately, such a registry can enhance patient care by informing clinical guidelines and fostering collaboration among clinicians, geneticists, and researchers in the field. Therefore, the goal of this observational study is to gather extensive clinical, genetic, and electrophysiological data from individuals with suspected or confirmed arrhythmogenic conditions. By systematically documenting patient demographics, family history, clinical presentations, diagnostic findings, and treatment outcomes, the registry aims to deepen our understanding of the genetic basis and clinical implications of genetically driven arrhythmias and systemic syndromes.
Interventions
None listed
Sponsors
University Hospital of Ferrara
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy. * Having a proven cardiogenetic disease
Exclusion criteria
* Refuse to provide informed consents * Patients not having a cardiogenic disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| All-cause of death | At one and 5 years (end of the study) | The investigators will monitor patient's all causes death |
| Cardiovascular-related death | At one and 5 years (end of the study) | The investigators will monitor patient's all causes death |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Onset/worsening of ventricular tachyarrhythmias | At one and 5 years (end of the study) | The investigators will monitor patient's rhythm over the years, assessing the onset or the worsening of ventricular tachyarrhythmias. |
| Onset or worsening heart faillure | At one and 5 years (end of the study) | The investigators will assess patient's hemodynamic stability over the years, monitoring the onset or the worsening of heart failure |
| Types of genetic mutations | At the time of genetic analysis | Types of genetic mutations |
| Need for PM/ICD | At one and 5 years (end of the study) | The investigators will evaluate procedural time of different cardiac pacing modalities |
| Onset/worsening of atrial tachyarrhythmias | At one and 5 years (end of the study) | — |
Countries
Italy
Contacts
Primary ContactCristina Balla, MD PhD
Outcome results
None listed